Navigation Links
Predicting drug responsiveness in cancer patients
Date:7/26/2010

Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such drugs.

Specifically, the team found that human cancer cells with mutations in the PIK3CA gene responded to everolimus in vitro except when a KRAS gene mutation was also present. Importantly, in a cohort of metastatic cancer patients, the presence of KRAS gene mutations was associated with lack of response to treatment with everolimus therapy. These data suggest that by looking for the presence or absence of PIK3CA and KRAS mutations in a person's tumor it will be possible to predict whether or not that person will benefit from treatment with a drug that targets mTOR. However, as noted in an accompanying commentary, by Morassa Mohseni and Ben Ho Park, at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, while these data have enormous potential to change clinical practice, larger prospective studies are required to verify them.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. MSU scientists develop more effective method of predicting lead-poisoning risk
2. Newer Genetic Info Adds Little to Predicting Breast Cancer
3. Breakthrough in Predicting Invasive Breast Cancer
4. Nasendoscopy proves useful in predicting treatment success in sleep apnea patients
5. Traditional neurologic exams inadequate for predicting survival of cardiac arrest patients
6. Predicting Alzheimers Risk in Patients With Cognitive Problems
7. Enhancing arrest of cell growth to treat cancer in mice
8. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
9. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
10. Low forms of cyclin E reduce breast cancer drugs effectiveness
11. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 27, 2017 , ... Two residents from the Gardant-managed assisted living and memory ... to encourage lawmakers to protect Medicaid funding. , The video, which was produced by ... story of Chuck and Cathy Schwarz, a couple who is still able to see ...
(Date:6/27/2017)... ... June 27, 2017 , ... Dr. Richard Amato, a respected ... his practice, Advanced Periodontics and Dental Implant Center of Connecticut. As part of the ... waiting areas. The renovations are intended to improve patient comfort while making it possible ...
(Date:6/27/2017)... ... ... Children’s National Health System received top honors in the 2017-18 U.S News & ... of more than 1500 neonatal intensive care units coast to coast. Children’s ... the top performing children’s hospitals in the country. , In addition to achieving ...
(Date:6/26/2017)... ... June 26, 2017 , ... Maryland’s soybean farmers have improved ... released by the United Soybean Board. , Thanks to the responsible use ... their productivity on less land per bushel, the report says. The United Soybean ...
(Date:6/26/2017)... ... ... New patients with missing teeth in Fitchburg, WI, can now ... Cotey is a trusted dentist who has placed many dental implants and enjoys teaching ... teeth in Fitchburg, WI, are encouraged to find out if they are candidates for ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading ... announced new findings demonstrating positive biochemical outcomes related to ... One™. The data will be presented at the ERA-EDTA ... Madrid, Spain . The research ... Dialysis Network in Europe ...
(Date:5/30/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ... will be presenting at the 7th annual LD Micro Invitational on ... , CEO, of DarioHealth will be giving the presentation and meeting ... 6th & 7th, 2017 at the Luxe Sunset Bel Air Hotel ... About LD Micro LD Micro ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
Breaking Medicine Technology: